Skip to main content

A civil case has been initiated in the claim of JSC Olainfarm for the damage caused

Written by Customer Service on . Posted in Public Companies.

Pursuant to the decision of the shareholders’ meeting of September 22, 2020, the Management Board of JSC Olainfarm has filed a lawsuit against the former members of the Management Board of JSC Olainfarm. By the decision of the Vidzeme Suburb Court of Riga City on 12th of April 2021, a civil case has been initiated in the claim of JSC Olainfarm against former members of the Management Board who entered into an agreement with Banestar Management Limited, causing losses in the amount of EUR 26,067,760.05.

In April of 2019, the Management Board of JSC Olainfarm became acquainted with the economic activities of the company and the previously signed contracts. It identified transactions regarding marketing outsourcing services from Banestar Management Limited, a company registered in Cyprus, which raised doubts about their potential fictitious nature, economic validity and legitimacy. In addition, the amount of the contract did not match the number of services received and the marketing activities were lacking supporting documentation. Initially, cooperation with the company was temporarily terminated, then completely suspended and the company turned to the State Police that initiated criminal proceedings about the situation, declaring the company a victim. The suspicious transactions occurred between 2 January 2017 and 4 April 2019.

At the request of the person directing the criminal proceeding, in April 2019 JSC Olainfarm engaged an independent, international auditor to verify the reasonableness of business operations and the payment made for marketing services to the Cypriot company, realized by previous higher-level management. The auditor’s report, received in August 2019, indicates that an in-depth analysis confirmed – as a result of this transaction, potentially significant losses were caused to JSC “Olainfarm”.

Milana Beļeviča, Member of JSC Olainfarm Management Board emphasizes: “JSC Olainfarm is currently on the path of transformation, improving the efficiency and management of the company. Our goal is to improve the transparency of internal processes and decision-making, as well as to prevent such risks in the future in order to ensure sustainable operation of the company and added value to the company’s shareholders, employees, partners and society as a whole.”

Olainfarm, a part of Olainfarm Group, is one of the leading pharmaceutical companies in the Baltic States offering high quality medicine and chemical pharmaceutical products. The Group’s  business strategy “FORWARD” highlights the main company’s vision – to become one of the TOP10 Central and Eastern European manufacturing companies by 2025.

With nearly 50 years of expertise, Olainfarm Group delivers sustainable healthcare products and services with added value to patients in more than 50 countries all over the world via its key subsidiaries – pharmaceutical company Olainfarm, food supplements & medical devices producer Silvanols, elastic & compression material producer Tonus Elast, pharmacy chain Latvijas Aptieka and healthcare & diagnostics centres DiaMed & OlainMed.

Additional information:  
Jānis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
Email: janis.dubrovskis@olainfarm.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.